Italiano
EnglishInternational Projects
- DIAN-TU-001: A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multicenter Study of Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease.
Funded by Washington University School of Medicine in St. Louis (USA).
- Incremental diagnostic value of Florbetaben Imaging vs other core biomarkers for Alzheimer Disease in patients with Mild Cognitive Impairment.
An Investigator-Initiated Sponsored Study
- 18F-AV-45-A18: a randomized, multicenter, multicountry study to evaluate the effectiveness of Florbetapir (18F) PET imaging in changing patient management and to evaluate the relationship between florbetapir (18F) PET scan status and cognitive decline.
Funded by Avid Radiopharmaceuticals, Inc.
- HBP: Human Brain Project: To build biologically detailed simulations of the complete human brain and to create the informatics, modeling and supercomputing technologies necessary to do so.
Funded by European Commission, FP7
- AMYPAD: Amyloid imaging to Prevent Alzheimer’s Disease.
Funded by European Commission, IMI Innovative Medicines Initiative
- EMIF: European Medical Information Framework : to generate a common patient health Information Framework for the discovery and validation of disease biomarkers.
Funded by IMI – Innovative Medicines Initiative, through the Italian Ministry of Health
- GENFI: The GENetic Frontotemporal Dementia Initiative: a new multi-centre platform for the study of frontotemporal lobar degeneration.
Funded by the Italian Ministry of Health in the context of the International Network of Centres of Excellence in Neurodegeneration (CoEN)
- Biomark APD: The Biomarkers for Alzheimer’s disease and Parkinson’s disease.
Funded by Eu Joint Programme – Neurodegenerative Disease Research, through the Italian Ministry of Health
- N4U: neuGRID for you: expansion of neuGRID services and outreach to new user communities.
Funded by European Commission, FP7
- SOPs: Harmonization of Protocols for the Manual Tracing of the Hippocampus Development and Validation of a Unified Standard Protocol: An EADC-ADNI Joint Effort. [SOPs outline]
Funded by the Alzheimer’s Association and unrestricted grants from Lilly International and Wyeth International (a part of the Pfizer group)
- PHARMA-COG: Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development.
Funded by European Commission, IMI Innovative Medicines Initiative
WP5 – Identification of biomarkers sensitive to disease progression: Clinical Studies (European ADNI)
- outGRID: a worldwide e-Infrastructure for computational neuroscientists.
Funded by European Commission, FP7
- neuGRID: a grid-based e-infrastructure for data archiving/ communication and computationally intensive applications in the medical sciences.
Funded by European Commission, FP7
- BPD: Clinical and morphological cerebral features of Borderline Personalità Disorder and Bipolar Disorder.
Co-funded by AFaR – Associazione fatebenefratelli per la Ricerca
- pilot E-ADNI: The European Alzheimer’s Disease Neuroimaging Initiative: a pilot study of the European Alzheimer’s Disease Consortium.
Funded by Alzheimer’s Association, Chicago, USA